Results from a study using misoprostol for management of incomplete abortion in Vietnamese hospitals: Implications for task shifting

BMC Pregnancy and Childbirth

Volumn 13, Issue , 2013, Pages

  Ngoc, Nguyen Thi Nhu ^a   Shochet, Tara ^b   Blum, Jennifer ^c   Hai, Pham Thanh ^d   Dung, Duong Lan ^e   Nhan, Tran Thanh ^f   Winikoff, Beverly ^c  

^a Center for Research and Consultancy in Reproductive Health   (Viet Nam)

^b Gynuity Health Projects ^*

^c GYNUITY HEALTH PROJECTS   (United States)

^d Tu du Hospital   (Viet Nam)

^e National OBGYN hospital   (Viet Nam)

^f Cuchi General District hospital   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL;

ADULT; ARTICLE; CHILL; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; ECTOPIC PREGNANCY; FEMALE; FEVER; FOLLOW UP; HUMAN; INCOMPLETE ABORTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; OPEN STUDY; PATIENT SATISFACTION; QUESTIONNAIRE; SINGLE DRUG DOSE; UTERUS; VIET NAM; VOMITING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INCOMPLETE; ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; FEMALE; HOSPITAL ADMINISTRATION; HUMANS; MIDDLE AGED; MISOPROSTOL; PATIENT SATISFACTION; PHYSICIAN'S ROLE; QUESTIONNAIRES; VIETNAM; YOUNG ADULT;

EID: 84878008451     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-13-118     Document Type: Article

References (20)

1. World Health Organization (WHO) Unsafe abortion: Global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008 2011, Geneva: WHO, 6, World Health Organization (WHO).
2. Dao B, Blum J, Thieba B, Raghavan S, Ouedraego M, Lankoande J, Winikoff B. Is misoprostol a safe, effective and acceptable alternative to manual vacuum aspiration for postabortion care? Results from a randomised trial in Burkina Faso, West Africa. BJOG 2007, 114(11):1368-75. 10.1111/j.1471-0528.2007.01468.x, 17803715.
3. Bique C, Ustá M, Debora B, Chong E, Westheimer E, Winikoff B. Comparison of misoprostol and manual vacuum aspiration for the treatment of incomplete abortion. Int J Gynaecol Obstet 2007, 98(3):222-6. 10.1016/j.ijgo.2007.05.003, 17610879.
4. Weeks A, Alia G, Blum J, Winikoff B, Ekwaru P, Durocher J, Mirembe F. A randomized trial of misoprostol compared with manual vacuum aspiration for incomplete abortion. Obstet Gynecol 2005, 106(3):540-7. 10.1097/01.AOG.0000173799.82687.dc, 16135584.
5. Diop A, Raghavan S, Rakotovao JP, Comendant R, Blumenthal PD, Winikoff B. Two routes of administration for misoprostol in the treatment of incomplete abortion: A randomized clinical trial. Contraception 2009, 79(6):456-62. 10.1016/j.contraception.2008.11.016, 19442782.
6. Dabash R, Ramadan MC, Darwish E, Hassanein N, Blum J, Winikof B. A randomizes controlled trial of 400-μg sublingual misoprostol versus manual vacuum aspiration for the treatment of incomplete abortion in two Egyptian hospitals. Int J Gynaecol Obstet 2010, 111(2):131-5. 10.1016/j.ijgo.2010.06.021, 20801444.
7. Shochet T, Diop A, Gaye A, Nayama M, Sall AB, Bukola F, Blandine T, Abiola OM, Dao B, Olayinka O, Winikoff B. Sublingual misoprostol versus standard surgical care for treatment of incomplete abortion in five sub-Saharan African countries. BMC Pregnancy Childbirth 2012, 12(1):127. 10.1186/1471-2393-12-127, 3545859, 23150927.
8. Nguyen TN, Blum J, Durocher J, Quan TT, Winikoff B. A randomized controlled study comparing 600 versus 1,200 microg oral misoprostol for medical management of incomplete abortion. Contraception 2005, 72(6):438-42. 10.1016/j.contraception.2005.05.010, 16307967.
9. Neilson JP, Gyte GM, Hickey M, Vazquez JC, Dou L. Medical treatments for incomplete miscarriage (less than 24 weeks). Cochrane Database Syst Rev 2010, 20(1):CD007223.
10. Blandine T, Ouattara AZ, Coral A, Hassane C, Clotaire H, Dao B, Lankoande J, Diop A, Blum J. Oral misoprostol as first-line care for incomplete abortion in Burkina Faso. Int J Gynaecol Obstet 2012, 119(2):166-9. 10.1016/j.ijgo.2012.05.036, 22935621.
11. Fawole AO, Diop A, Adeyanju AO, Aremu OT, Winikoff B. Misoprostol as first-line treatment for incomplete abortion at a secondary-level health facility in Nigeria. Int J Gynaecol Obstet 2012, 119(2):170-3. 10.1016/j.ijgo.2012.06.012, 22935620.
12. Moreau C, Trussell J, Desfreres J, Bajos N. Medical vs. surgical abortion: the importance of women's choice. Contraception 2011, 84(3):224-9. 10.1016/j.contraception.2011.01.011, 21843684.
13. Ngoc N, Winikoff B, Clark S, Ellertson C, Am K, Hieu D, Elul B. Safety, Efficacy and Acceptability of Mifepristone-Misoprostol Medical Abortion in Vietnam. IntFam Plan Perspect 1999, 25(1):10-14.
14. Winikoff B, Sivin I, Coyaji K, Cabezas E, et al. The Acceptability of medical abortion in China, Cuba and India. Int Fam Plan Perspect 1997, 23:73-78.
15. World Health Organization Safe abortion: Technical and policy guidance for health systems 2012, Geneva: WHO, 2, World Health Organization.
16. World Health Organization WHO Model List of Essential Medicines.17th List 2011, Geneva: WHO, World Health Organization.
17. Venture Strategies Innovations (VSI) Postabortion care Available at: http://vsinnovations.org/pac.html. Accessed July 25, 2012, Venture Strategies Innovations (VSI).
18. Priority life-saving medicines for women for major causes of sexual and reproductive health related mortality and morbidity 2012, WHO, http://apps.who.int/iris/bitstream/10665/75154/1/WHO_EMP_MAR_2012.1_eng.pdf. Accessed January 15, 2013.
19. Fjerstad M. Figuring out follow-up. Mifematters PPFA/CAPS 2006, 13:2-3.
20. American College of Obstetricians and Gynecologists Misoprostol for postabortion care.ACOG Committee Opinion No. 427. Obstet Gynecol 2009, 113:465-8. American College of Obstetricians and Gynecologists.